340nok
3,7 %
Date:2025-01-10Time:09:22:26Latest report:Q4-2020List:Oslo GrowthTicker:ONCIN
Market Cap:314 mnokEnterprise Value:314 mnokNet Sales:- mnokEarnings:- mnokEmployees:0ISIN:NO0010779341

Ratios

10-year key figure history for Oncoinvent turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Oncoinvent with index and moving average MA50 and MA200.

Stockprice:3,40
MA50:-
MA200:-
Price/MA200:-
RSI (14):-
Price/MA50:-

Description

Oncoinvent is a clinical-stage radiopharmaceutical company developing treatments for solid cancers. The technology platform is focused on the use of alpha-emitting radionuclides to deliver radiation directly to cancer cells. The company's product candidate, Radspherin, is an alpha radiotherapy candidate designed for the local treatment of cancer that has spread to body cavities. Oncoinvent is headquartered in Oslo.

Medical Equipment